Coagulation and Fibrinolysis Gly 74 Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MAESTROweb: a web server for structure-based protein stability prediction

  2016cited by this paper
• The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins

  2015cited by this paper
• Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays.

  2015cited by this paper
• Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology

  2014cited by this paper
• Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis

  2013cited by this paper
• Expression and functional characterization of natural R147W and K150del variants of protein C in the Chinese population

  2013cited by this paper
• One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade.

  2013cited by this paper
• Protein–protein interaction sites are hot spots for disease‐associated nonsynonymous SNPs

  2012cited by this paper
• Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue.

  2011influential reference
• Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain

  2010cited by this paper
• Eris: an automated estimator of protein stability

  2007cited by this paper
• Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain*

  2006cited by this paper
• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway

  2006cited by this paper
• The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.

  2005cited by this paper
• Specificity of coagulation factor signaling

  2003cited by this paper
• Calibrated Automated Thrombin Generation Measurement in Clotting Plasma

  2003cited by this paper
• Importance of Protein S and Phospholipid for Activated Protein C-mediated Cleavages in Factor Va*

  2003cited by this paper
• Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B

  2002cited by this paper
• Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements.

  2002cited by this paper
• Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.

  2002cited by this paper
• Screening the molecular surface of human anticoagulant protein C: A search for interaction sites

  2001cited by this paper
• Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S.

  2000cited by this paper
• Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

  1998cited by this paper
• Amino Acid Residues in Thrombin-sensitive Region and First Epidermal Growth Factor Domain of Vitamin K-dependent Protein S Determining Specificity of the Activated Protein C Cofactor Function*

  1998cited by this paper
• Topological Studies of the Amino Terminal Modules of Vitamin K-dependent Protein S Using Monoclonal Antibody Epitope Mapping and Molecular Modeling

  1998cited by this paper
• The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the γ-Carboxyglutamic Acid Domain of Protein C*

  1997cited by this paper
• A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: From biostructural pathology to specie

  1997cited by this paper
• The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

  1996cited by this paper
• The 2.8 A crystal structure of Gla‐domainless activated protein C.

  1996influential reference
• The protein C anticoagulant system: inherited defects as basis for venous thrombosis.

  1995cited by this paper
• Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*)

  1995cited by this paper
• Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity.

  1995cited by this paper
• Protein C Deficiency: A Database of Mutations, 1995 Update

  1995cited by this paper
• Effects of Protein S and Factor Xa on Peptide Bond Cleavages during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*)

  1995cited by this paper
• Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.

  1994cited by this paper
• Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1.

  1994cited by this paper
• Role of the membrane in the inactivation of factor Va by activated protein C.

  1993cited by this paper
• Molecular Events that Control the Protein C Anticoagulant Pathway

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper
• Regulation of blood coagulation by the protein C system

  1992cited by this paper
• Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors.

  1991influential reference
• Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity.

  1988cited by this paper
• Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.

  1988cited by this paper
• Changes in the plasma levels of vitamin K‐dependent proteins C and S and of C4b‐binding protein during pregnancy and oral contraception

  1988cited by this paper
• Oral contraceptives and gender affect protein S status.

  1987cited by this paper
• Characterization of a cDNA coding for human protein C.

  1984influential reference
• Deficiency of protein C in congenital thrombotic disease.

  1981cited by this paper

• No citing papers are available for this paper.